Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL - US2197981051 - Common Stock

27.77 USD
-0.15 (-0.54%)
Last: 8/27/2025, 5:20:01 PM
27.77 USD
0 (0%)
After Hours: 8/27/2025, 5:20:01 PM
Fundamental Rating

4

Overall QDEL gets a fundamental rating of 4 out of 10. We evaluated QDEL against 185 industry peers in the Health Care Equipment & Supplies industry. QDEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on QDEL.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

QDEL had positive earnings in the past year.
In the past year QDEL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
QDEL had a positive operating cash flow in each of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

The Return On Assets of QDEL (-7.31%) is better than 63.78% of its industry peers.
Looking at the Return On Equity, with a value of -16.70%, QDEL is in the better half of the industry, outperforming 60.54% of the companies in the same industry.
QDEL has a Return On Invested Capital of 1.72%. This is in the better half of the industry: QDEL outperforms 68.11% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QDEL is below the industry average of 8.44%.
Industry RankSector Rank
ROA -7.31%
ROE -16.7%
ROIC 1.72%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

The Operating Margin of QDEL (4.15%) is better than 67.57% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
QDEL has a Gross Margin of 47.29%. This is comparable to the rest of the industry: QDEL outperforms 41.08% of its industry peers.
QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.15%
PM (TTM) N/A
GM 47.29%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
The number of shares outstanding for QDEL has been increased compared to 1 year ago.
QDEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for QDEL is higher compared to a year ago.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.80, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
QDEL has a Altman-Z score (0.80) which is comparable to the rest of the industry.
The Debt to FCF ratio of QDEL is 200.49, which is on the high side as it means it would take QDEL, 200.49 years of fcf income to pay off all of its debts.
QDEL has a better Debt to FCF ratio (200.49) than 64.32% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that QDEL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, QDEL is doing worse than 74.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 200.49
Altman-Z 0.8
ROIC/WACC0.24
WACC7.11%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.12 indicates that QDEL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, QDEL is doing worse than 86.49% of the companies in the same industry.
QDEL has a Quick Ratio of 1.12. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QDEL (0.62) is worse than 91.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.62
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for QDEL have decreased by -4.10% in the last year.
The Earnings Per Share has been decreasing by -9.03% on average over the past years.
The Revenue has decreased by -3.28% in the past year.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-4.1%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%271.43%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.63%

3.2 Future

The Earnings Per Share is expected to grow by 24.45% on average over the next years. This is a very strong growth
QDEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y31.32%
EPS Next 2Y33.68%
EPS Next 3Y32.36%
EPS Next 5Y24.45%
Revenue Next Year-2.3%
Revenue Next 2Y0.51%
Revenue Next 3Y1.97%
Revenue Next 5Y1.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.87, which indicates a very decent valuation of QDEL.
Compared to the rest of the industry, the Price/Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 91.35% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.14. QDEL is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.40, which indicates a very decent valuation of QDEL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 96.22% of the companies listed in the same industry.
QDEL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 11.87
Fwd PE 8.4
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

95.14% of the companies in the same industry are more expensive than QDEL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QDEL is valued a bit cheaper than the industry average as 68.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 145.04
EV/EBITDA 7.86
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 32.36% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y33.68%
EPS Next 3Y32.36%

More info and screens

0

5. Dividend

5.1 Amount

QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUIDELORTHO CORP

NASDAQ:QDEL (8/27/2025, 5:20:01 PM)

After market: 27.77 0 (0%)

27.77

-0.15 (-0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners114.52%
Inst Owner Change5.72%
Ins Owners0.58%
Ins Owner Change2.36%
Market Cap1.89B
Analysts77.33
Price Target44.88 (61.61%)
Short Float %9.83%
Short Ratio4.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)357.74%
Min EPS beat(2)23.78%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)220.56%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)120.88%
EPS beat(12)10
Avg EPS beat(12)95.2%
EPS beat(16)13
Avg EPS beat(16)76.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)-1.51%
Revenue beat(4)1
Avg Revenue beat(4)1.81%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)11.02%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)8
Avg Revenue beat(12)2.33%
Revenue beat(16)11
Avg Revenue beat(16)4.56%
PT rev (1m)-10.2%
PT rev (3m)-17.43%
EPS NQ rev (1m)-15.54%
EPS NQ rev (3m)-8.93%
EPS NY rev (1m)-0.97%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 11.87
Fwd PE 8.4
P/S 0.69
P/FCF 145.04
P/OCF 9.41
P/B 0.68
P/tB N/A
EV/EBITDA 7.86
EPS(TTM)2.34
EY8.43%
EPS(NY)3.31
Fwd EY11.9%
FCF(TTM)0.19
FCFY0.69%
OCF(TTM)2.95
OCFY10.63%
SpS40.38
BVpS41.13
TBVpS-8.53
PEG (NY)0.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.31%
ROE -16.7%
ROCE 2.17%
ROIC 1.72%
ROICexc 1.77%
ROICexgc 5.25%
OM 4.15%
PM (TTM) N/A
GM 47.29%
FCFM 0.47%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 200.49
Debt/EBITDA 3.74
Cap/Depr 42.61%
Cap/Sales 6.84%
Interest Coverage 250
Cash Conversion 36.19%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.62
Altman-Z 0.8
F-Score5
WACC7.11%
ROIC/WACC0.24
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.1%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%271.43%
EPS Next Y31.32%
EPS Next 2Y33.68%
EPS Next 3Y32.36%
EPS Next 5Y24.45%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.63%
Revenue Next Year-2.3%
Revenue Next 2Y0.51%
Revenue Next 3Y1.97%
Revenue Next 5Y1.95%
EBIT growth 1Y8.79%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year933.51%
EBIT Next 3Y133.77%
EBIT Next 5Y88.82%
FCF growth 1Y-88.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.98%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%